Between 1987 and 2007, the number of people receiving treatment for depression in the United States increased fourfold (and has continued to rise more gradually since). However, the prevalence of depression either stayed the same—or may have even increased—during that time. Researchers call this the “treatment-prevalence paradox” (TPP).
* Browse through a DSM for all the codes that allow billing to insurance and you’ll find every human emotion , every sickness , every disease and you can bet the pharmacy has an antidepressant for that particular issue .
No science. Read the facts of how efficiently testing is done or not.
Ready of the kin ship between FDA who usually rewards the best show , not the best product.
The horrific loss of life and families erased as mine was began in 1987 with the huge push to diagnosis bipolar which presented in varied ways .
Their eyes are wide shut about these side effects and society accepted , the law embraced the all knowing wizards of Pharma and suicide was normalized by many especially 80’s
Ignoring thus supporting abuse Knowing thus supporting the trauma .
For these reasons and more , having personally exited that matrix , I’m aware there are many like I was ; induced into a state of Ill health and toxic mind and endured 5 years of neglect , abandonment , having no interest in my life , before leaving for another 20 year period aligned with his twin .
Learning nothing , his shadow is depressive , and I’m eager to complete business and no contact ever .
Coming to and regaining , renewing my essence was hellish in many respects but invaluable to my healing process .
Blessings& Peace ❤️☮️
Dona Luna 🐸
Now, in a new study, researchers review the seven possible explanations for this—and the evidence for and against each one. The study was led by Johan Ormel at the University of Groningen, The Netherlands, and published in Clinical Psychology Review.
Ormel and his co-authors explain:
“The increased availability of effective treatments should shorten depressive episodes, reduce relapses, and curtail recurrences. Combined, these treatment advances unequivocally should result in lower point-prevalence estimates of depression. Have these reductions occurred? The empirical answer clearly is NO.”
Despite More Treatments for Depression, Prevalence Doesn’t Decrease—Why?
www.madinamerica.com/2022/10/treatment-depression-increased/
GreatCosmicMothersUnite 